273 related articles for article (PubMed ID: 19473751)
1. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
Palmieri A; Imbimbo C; Longo N; Fusco F; Verze P; Mangiapia F; Creta M; Mirone V
Eur Urol; 2009 Aug; 56(2):363-9. PubMed ID: 19473751
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
[TBL] [Abstract][Full Text] [Related]
3. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal Shockwave Therapy in Peyronie's Disease: Systematic Review and Meta-Analysis.
Bakr AM; El-Sakka AI
J Sex Med; 2021 Oct; 18(10):1705-1714. PubMed ID: 34511369
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
[TBL] [Abstract][Full Text] [Related]
6. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
[TBL] [Abstract][Full Text] [Related]
7. The impact of extracorporeal shock wave therapy for the treatment of young patients with vasculogenic mild erectile dysfunction: A prospective randomized single-blind, sham controlled study.
Ortac M; Özmez A; Cilesiz NC; Demirelli E; Kadıoğlu A
Andrology; 2021 Sep; 9(5):1571-1578. PubMed ID: 33780173
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study.
Zimmermann R; Cumpanas A; Miclea F; Janetschek G
Eur Urol; 2009 Sep; 56(3):418-24. PubMed ID: 19372000
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
Fojecki GL; Tiessen S; Osther PJ
World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
[TBL] [Abstract][Full Text] [Related]
10. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease.
Dell'Atti L; Ronchi P
World J Urol; 2023 Sep; 41(9):2563-2568. PubMed ID: 37490060
[TBL] [Abstract][Full Text] [Related]
11. Shockwave Therapy in the Treatment of Peyronie's Disease.
Krieger JR; Rizk PJ; Kohn TP; Pastuszak A
Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.
Safarinejad MR
Int J Impot Res; 2010; 22(5):298-309. PubMed ID: 20720560
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity.
Strebel RT; Suter S; Sautter T; Hauri D
Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline).
Lebret T; Loison G; Hervé JM; Mc Eleny KR; Lugagne PM; Yonneau L; Orsoni JL; Saporta F; Butreau M; Botto H
Urology; 2002 May; 59(5):657-61. PubMed ID: 11992835
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of extracorporeal shockwave therapy for Peyronie's disease.
Srirangam SJ; Manikandan R; Hussain J; Collins GN; O'Reilly PH
J Endourol; 2006 Nov; 20(11):880-4. PubMed ID: 17144855
[TBL] [Abstract][Full Text] [Related]
16. [Low-intensity extracorporeal shockwave therapy for Peyronie's disease: A preliminary study of 32 cases].
Li PC; Chen X; Zhu XB; Shi T; Song F; Huang HW; Zhang XS
Zhonghua Nan Ke Xue; 2018 Apr; 24(4):340-344. PubMed ID: 30168955
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study.
Di Mauro M; Russo GI; Della Camera PA; Di Maida F; Cito G; Mondaini N; Capece M; Falcone M; Sessa F; Mari A; Campi R; Sabini C; Serni S; Gacci M; Minervini A; Carini M; Cimino S; Morelli G; Cocci A
World J Mens Health; 2019 Sep; 37(3):339-346. PubMed ID: 30929330
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.
Hauck EW; Mueller UO; Bschleipfer T; Schmelz HU; Diemer T; Weidner W
J Urol; 2004 Feb; 171(2 Pt 1):740-5. PubMed ID: 14713800
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: long-term results.
De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V
Arch Ital Urol Androl; 2010 Jun; 82(2):128-33. PubMed ID: 20812541
[TBL] [Abstract][Full Text] [Related]
20. Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report.
Shimpi RK; Jain RJ
Urol Ann; 2016; 8(4):409-417. PubMed ID: 28057983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
